Market Focus Target medical centers and hospitals that specialize in breast cancer treatment and radiotherapy, emphasizing GammaPod’s noninvasive, precise stereotactic radiotherapy as a patient-friendly alternative to traditional radiation.

Strategic Partnerships Leverage collaborations and licensing backgrounds with university medical centers and institutions involved in radiotherapy innovation, highlighting adoption potential in clinics seeking cutting‑edge, noninvasive cancer care technologies.

Global Outreach Capitalize on recent international participation at ESTRO and Arab Health to approach regional cancer centers and distributors in Europe and the Middle East, presenting GammaPod demonstrations and case studies.

Financial Readiness Position GammaPod as a scalable growth opportunity for small to mid-sized radiotherapy vendors and hospital systems with mid‑range revenue potential, aligning with a lean sales cycle and demonstrable ROI.

Technical Leverage Highlight the GammaPod’s high precision, noninvasive treatment benefits and potential collaboration with existing radiotherapy hardware ecosystems, offering integration and service plans suitable for adoption by providers currently exploring advanced SBRT options.